BREVITAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Brevital Sodium, and when can generic versions of Brevital Sodium launch?
Brevital Sodium is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in BREVITAL SODIUM is methohexital sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methohexital sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brevital Sodium
A generic version of BREVITAL SODIUM was approved as methohexital sodium by STERISCIENCE on October 3rd, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BREVITAL SODIUM?
- What are the global sales for BREVITAL SODIUM?
- What is Average Wholesale Price for BREVITAL SODIUM?
Summary for BREVITAL SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 12 |
| Clinical Trials: | 1 |
| Patent Applications: | 780 |
| Drug Prices: | Drug price information for BREVITAL SODIUM |
| What excipients (inactive ingredients) are in BREVITAL SODIUM? | BREVITAL SODIUM excipients list |
| DailyMed Link: | BREVITAL SODIUM at DailyMed |
Recent Clinical Trials for BREVITAL SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | N/A |
Pharmacology for BREVITAL SODIUM
| Drug Class | Barbiturate |
US Patents and Regulatory Information for BREVITAL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | BREVITAL SODIUM | methohexital sodium | INJECTABLE;INJECTION | 011559-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | BREVITAL SODIUM | methohexital sodium | INJECTABLE;INJECTION | 011559-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Endo Operations | BREVITAL SODIUM | methohexital sodium | INJECTABLE;INJECTION | 011559-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | BREVITAL SODIUM | methohexital sodium | INJECTABLE;INJECTION | 011559-004 | Dec 21, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
